Literature DB >> 31160279

Lung cancer.

Richard D Neal1, Fei Sun2, Jon D Emery3, Matthew E Callister2.   

Abstract

Entities:  

Mesh：

Year:  2019        PMID： 31160279     DOI： 10.1136/bmj.l1725

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  21 in total

1.  Transketolase Serves as a Biomarker for Poor Prognosis in Human Lung Adenocarcinoma.

Authors:  Cong Niu; Wenjia Qiu; Xiangyang Li; Hongqing Li; Ji'an Zhou; Huili Zhu
Journal:  J Cancer       Date:  2022-05-13       Impact factor: 4.478

2.  LncRNA LINC01116 Contributes to Cisplatin Resistance in Lung Adenocarcinoma.

Authors:  Junbin Wang; Jin Gao; Qinnan Chen; Weiyan Zou; Fen Yang; Chenchen Wei; Zhaoxia Wang
Journal:  Onco Targets Ther       Date:  2020-09-22       Impact factor: 4.147

3.  Effect of CT-guided microwave ablation for non-small cell lung cancer combined with severe chronic obstructive pulmonary disease.

Authors:  Zhenhua Rong; Yongqi Ji; Faliang Dai; Fangfang Zhang; Yan Jiao; Yixing Liu
Journal:  Am J Transl Res       Date:  2021-11-15       Impact factor: 4.060

4.  Role of Long Noncoding RNAs in Smoking-Induced Lung Cancer: An In Silico Study.

Authors:  Lei Ge; Shishun Zhao; Jianguo Sun; Jianhua Cheng; Shaokun Wang
Journal:  Comput Math Methods Med       Date:  2022-04-30       Impact factor: 2.809

5.  Changes in the presenting symptoms of lung cancer from 2000-2017: a serial cross-sectional study of observational records in UK primary care.

Authors:  Sarah Chowienczyk; Sarah Price; Willie Hamilton
Journal:  Br J Gen Pract       Date:  2020-02-27       Impact factor: 5.386

Review 6.  P2X Receptors: Potential Therapeutic Targets for Symptoms Associated With Lung Cancer - A Mini Review.

Authors:  Yonglin Mai; Zhihua Guo; Weiqiang Yin; Nanshan Zhong; Peter V Dicpinigaitis; Ruchong Chen
Journal:  Front Oncol       Date:  2021-06-29       Impact factor: 6.244

7.  Development and validation of a robust immune-related prognostic signature in early-stage lung adenocarcinoma.

Authors:  Pancheng Wu; Yi Zheng; Yanyu Wang; Yadong Wang; Naixin Liang
Journal:  J Transl Med       Date:  2020-10-07       Impact factor: 5.531

8.  Personalized neoantigen pulsed dendritic cell vaccine for advanced lung cancer.

Authors:  Zhenyu Ding; Qing Li; Rui Zhang; Li Xie; Yang Shu; Song Gao; Peipei Wang; Xiaoqing Su; Yun Qin; Yuelan Wang; Juemin Fang; Zhongzheng Zhu; Xuyang Xia; Guochao Wei; Hui Wang; Hong Qian; Xianling Guo; Zhibo Gao; Yu Wang; Yuquan Wei; Qing Xu; Heng Xu; Li Yang
Journal:  Signal Transduct Target Ther       Date:  2021-01-20

9.  Evaluation of a Low-Dose Computed Tomography Lung Cancer Screening Program in Henan, China.

Authors:  Lan-Wei Guo; Qiong Chen; Yin-Chen Shen; Qing-Cheng Meng; Li-Yang Zheng; Yue Wu; Xiao-Qin Cao; Hui-Fang Xu; Shu-Zheng Liu; Xi-Bin Sun; You-Lin Qiao; Shao-Kai Zhang
Journal:  JAMA Netw Open       Date:  2020-11-02

10.  METTL3‑mediated m6A modification of Bcl‑2 mRNA promotes non‑small cell lung cancer progression.

Authors:  Yongxi Zhang; Shuyuan Liu; Tiesuo Zhao; Chengxue Dang
Journal:  Oncol Rep       Date:  2021-06-16       Impact factor: 3.906
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.